glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Insights into the Roles of GLP-1, DPP-4, SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology Practice Nursing - GLP-1 receptor
Description
doi: 10.1016/j.neuint.2020.104707 12 BaeCSSongJ
This helps to manage any side effects and health issues that might come up, including those related to breast milk
Starting at 1mg for at least two to four weeks remains the recommended approach even for experienced researchers transitioning from other incretin therapies
MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AM, Light PE, Wheeler MB
